Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The input "ceftriaxone or doxycycline" refers to two distinct antibiotic drugs, ceftriaxone and doxycycline, rather than a single drug or a combination product. Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, primarily used for treating various bacterial infections, including severe ones like meningitis and gonorrhea. Doxycycline is a tetracycline antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, effective against a broad spectrum of bacteria and also used for malaria prevention and acne treatment. Due to the disjunctive nature of the input, specific information for a single drug cannot be provided.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ceftriaxone or doxycycline.